Foreign was Serina Therapeutics’s largest region in fiscal 2022, bringing in $24.00K of $34.00K (71%).
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2021 | FY 2022 |
|---|---|---|---|---|---|
| United States | $986.00K | $107.00K | $10.00K | ||
| Foreign | $742.00K | $37.00K | $24.00K | ||
| Total | $1.73M | $144.00K | $34.00K |
Serina Therapeutics brought in $34.00K from its two regions in fiscal 2022, the year ended December 31, 2022. That was down 76.4% from $144.00K in fiscal 2021. Foreign was the largest at $24.00K (70.6%), ahead of United States at $10.00K (29.4%).
Compared with fiscal 2021, Foreign fell 35.1% to $24.00K and United States fell 90.7% to $10.00K. From fiscal 2019 to 2022, combined revenue from these regions fell from $1.73M to $34.00K, a compound annual decline of 73.0%. Foreign's share of the total rose from 42.9% to 70.6%.
Serina Therapeutics (SER) reports its revenue by geography. In fiscal 2022, Foreign was its largest region, bringing in $24.00K (70.6% of the total), followed by United States at $10.00K (29.4%).
Foreign was Serina Therapeutics' largest region in fiscal 2022, bringing in $24.00K, or 70.6% of the $34.00K total across its two regions.
Every figure comes from Serina Therapeutics' annual financial filings, as reported. Each line keeps the name Serina Therapeutics gives it, and years follow its fiscal calendar.
Serina Therapeutics' revenue by geography goes back to fiscal 2017, with figures through fiscal 2022. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.